Nasal swine flu vaccine recalled over potency

Dec 22, 2009

(AP) -- Drugmaker Medimmune is recalling nearly 5 million doses of swine flu vaccine because the nasal spray appears to lose strength over time.

The Food and Drug Administration said Tuesday that the vaccine is safe and patients who received the product should be protected from the H1N1 virus.

The FDA says the vast majority of the doses have already been distributed and used. Agency officials say the vaccine met potency specifications when it was distributed in October and November.

Last week, another vaccine maker recalled shots for children because tests indicated those doses lost some strength.

Explore further: Vaccine for West Nile Virus enters human clinical trials

0 shares

Related Stories

Kids' Swine flu shots recalled; not strong enough

Dec 15, 2009

(AP) -- Hundreds of thousands of swine flu shots for children have been recalled because tests indicate the vaccine doses lost some strength, government health officials said Tuesday.

Flu season: How many shots?

Aug 30, 2009

(AP) -- Doctors don't know yet if it will take one dose or two of vaccine to protect against the new swine flu. Add that to vaccine for the regular winter flu, and it could be a multishot season for a lot of people - or ...

Recommended for you

Vaccine for West Nile Virus enters human clinical trials

2 hours ago

A clinical trial of a new investigational vaccine designed to protect against West Nile Virus infection will be sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes ...

FDA clears drug for leading form of cystic fibrosis

Jul 02, 2015

Federal health officials have approved a new combination drug for the most common form of cystic fibrosis, the debilitating inherited disease that causes internal mucus buildup, lung infections and early death. But it will ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.